Information  X 
Enter a valid email address

Inchcape PLC (INCH)

  Print      Mail a friend       Annual reports

Friday 08 November, 2019

Inchcape PLC

Replacement: Transaction in Own Shares

RNS Number : 8761S
Inchcape PLC
08 November 2019
 

REPLACEMENT : Transactions in own shares

 

 

The following amendments have been made to the 'Transaction in Own Shares' announcement released on 07/11/2019 at 18:29 under RNS No 7176S

 

The Company wishes to make aware the associated dealing costs of the buyback programme as of 07/11/2019 were £83,184,224.75 and not £78,051,633.19.

 

All other details remain unchanged.

 

The full amended text is shown below.

 

 

Inchcape plc (the Company) announces today it has purchased the following number of its ordinary shares of 10 pence from J.P. Morgan Securities plc as part of the buyback programme announced on 23 May 2019.

 

Date of purchase:

 

7 November 2019

Aggregate number of ordinary shares purchased:

 

264

Lowest price paid per share:

 

633.5000

Highest price paid per share:

 

633.5000

Average price paid per share:

 

633.5000

 

The Company intends to cancel the purchased shares.

 

Since 24 May 2019 the Company has purchased 13,708,902 shares at a cost (including dealing and associated costs) of £83,184,224.75.

 

The schedule below contains detailed information about the purchases made by J.P. Morgan Securities plc on behalf of the Company as part of the buyback programme.

 

Schedule of Purchases

 

Shares purchased:

 

Inchcape plc (ISIN: GB00B61TVQ02)

Date of purchases:

 

7 November 2019

Investment firm:

 

J.P. Morgan Securities plc

Aggregate information:

 

 

Venue

Volume-weighted average price

Aggregated volume

Lowest price per share

Highest price per share

London Stock Exchange

633.5000

264

633.5000

633.5000

Enquiries:

Tamsin Waterhouse

Company Secretary

Tel: +44 (0)20 7546 0022


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
POSBPBPTMBMMBBL

a d v e r t i s e m e n t